Clinical Trial Update: Alleviation by Fisetin of Frailty, Inflammation, and Related Measures in Older Adults [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating fisetin for reducing frailty and inflammation in frail older adults; currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Frailty Syndrome

Drugs mentioned

• Fisetin (fisetin)

Snippet

Sponsor: Mayo Clinic | Conditions: Frail Elderly Syndrome | Phase 2 | Status: ENROLLING_BY_INVITATION